Kowalski Marek K, Domżał-Magrowska Danuta, Szcześniak Piotr, Bulska Magdalena, Orszulak-Michalak Daria, Małecka-Wojciesko Ewa
Department of Digestive Tract Diseases, Medical University of Lodz, 90-153 Lodz, Poland.
Department of Biopharmacy, Medical University of Lodz, 90-151 Lodz, Poland.
Foods. 2024 Dec 31;14(1):76. doi: 10.3390/foods14010076.
Celiac disease (CD) is an autoimmune disease that results from the interaction of genetic, immune, and environmental factors. According to the 2020 European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guidelines, an elimination diet (i.e., excluding products that may contain gluten) is the basic method of treating celiac disease. Following a gluten-free diet is extremely problematic, and patients often make unconscious deviations from the diet. According to the current Oslo definitions for celiac disease, depending on the clinical picture and adequate tests, several forms of celiac disease have been identified: typical, atypical, asymptomatic, potential, and refractory.
The aim of the study was to assess the frequency of conscious diet mistakes and unconscious deviations from a gluten-free diet in a group of patients with long-standing celiac disease and their impact on the frequency of typical and atypical symptoms.
The study included 57 people diagnosed with celiac disease between 1980 and 2010. After verifying the history of the disease according to the ESPGHAN guidelines from 2020, we excluded 19 patients who had Marsh grade 1 at the time of diagnosis or those without HLA DQ2 or DQ8 haplotypes detected. After verification, the study included 38 patients, 30 women and 8 men, with a verified diagnosis of typical celiac disease. The effectiveness of the gluten-free diet was assessed in all participants. Blood was collected to determine IgA anti-tissue transglutaminase II antibodies (anti-tTG) and IgG antibodies against deamidated gliadin peptides by ELISA. All survey participants provided data concerning current gastrointestinal and systemic symptoms, bowel habits, comorbidities, dietary habits, physical activity, and socioeconomic conditions.
A total of 25 patients (65.78%) declared strict adherence to the gluten-free diet. However, in this group, seven (18.4%) patients had significantly increased levels of anti-tTG antibodies (mean 82.3 RU/mL ± 78.9 SD at N < 20 RU/mL). Among the patients who consciously made dietary mistakes, six (46.2%) demonstrated increased levels of anti-tTG antibodies. The analysis did not reveal any difference between the frequency of intestinal and extraintestinal symptoms in patients making dietary mistakes and following the gluten-free diet.
More than half of celiac patients unconsciously or consciously make dietary mistakes, which indicates an urgent need to increase their general knowledge of CD and the appropriate diet. Regardless of whether the gluten-free diet is followed, both typical and atypical symptoms of the disease have been observed among celiac patients.
乳糜泻(CD)是一种由遗传、免疫和环境因素相互作用导致的自身免疫性疾病。根据2020年欧洲儿科胃肠病、肝病和营养学会(ESPGHAN)指南,排除饮食法(即排除可能含麸质的产品)是治疗乳糜泻的基本方法。遵循无麸质饮食极具挑战性,患者常常会无意识地偏离这种饮食。根据当前乳糜泻的奥斯陆定义,依据临床表现和充分的检测,已确定了几种乳糜泻形式:典型型、非典型型、无症状型、潜在型和难治型。
本研究旨在评估一组长期患有乳糜泻的患者有意识的饮食错误及无意识偏离无麸质饮食的频率,以及它们对典型和非典型症状频率的影响。
本研究纳入了1980年至2010年间被诊断为乳糜泻的57人。根据2020年ESPGHAN指南核实疾病史后,我们排除了19例诊断时处于马什1级或未检测到HLA DQ2或DQ8单倍型的患者。核实后,研究纳入了38例患者,其中30名女性和8名男性,均被确诊为典型乳糜泻。评估了所有参与者无麸质饮食的效果。通过酶联免疫吸附测定法(ELISA)采集血液以测定抗组织转谷氨酰胺酶II抗体(抗tTG)和抗脱酰胺麦醇溶蛋白肽的IgG抗体。所有调查参与者提供了有关当前胃肠道和全身症状、排便习惯、合并症、饮食习惯、身体活动及社会经济状况的数据。
共有25例患者(65.78%)宣称严格遵循无麸质饮食。然而,在这组患者中,7例(18.4%)患者的抗tTG抗体水平显著升高(在正常水平<20 RU/mL时,平均为82.3 RU/mL±78.9标准差)。在有意识犯饮食错误的患者中,6例(46.2%)的抗tTG抗体水平升高。分析未发现犯饮食错误的患者与遵循无麸质饮食的患者在肠道和肠道外症状频率上有任何差异。
超过半数的乳糜泻患者会无意识或有意识地犯饮食错误,这表明迫切需要提高他们对乳糜泻及合适饮食的一般认知。无论是否遵循无麸质饮食,乳糜泻患者中均观察到了该疾病的典型和非典型症状。